Improvement in the quality of molecular analysis of <i>EGFR</i> in non-small-cell lung cancer detected by three rounds of external quality assessment

Abstract

Improvements in all these areas were observed during the progression of the three EQA rounds, however, continuous unacceptably high genotyping error rates demonstrate the clear need for continual external assessment and education in this field.